110 computer-"https:"-"APOS-UFFICIO-CONCORSI-DOCENTI" "https:" "https:" "https:" "https:" "https:" "Dr" positions at University of Washington
Sort by
Refine Your Search
-
in prostate cancer. We are currently working closely with Dr. Robert Schreiber on the first trial of neoantigen vaccines in prostate cancer patients. Our lab will focus on analyses of all patient
-
at both the UW Medical Center – Northwest Campus and Fred Hutchinson Cancer Center sites. Under the direction of Dr. Brian Dontchos, the section is closely integrated with clinical and research programs
-
program, with an anticipated start date of July 1. Acting instructors hold annual appointments that align with a 12-month service period (July 1-June 30) and may be reappointed to subsequent annual terms
-
, and program performance evaluation. The work includes working with investigators and other study coordinators to define study implementation processes and develop IRB applications, helping to design and
-
Scheduled Hours 40 Position Summary Dr. Wang’s lab uses in vivo mouse and in vitro cell models to investigate signaling networks underlying ocular tissue development and the mechanisms of ocular
-
for Students (DRS), Counseling Center and Hall Health, International Student Services (ISS), and other campus units to address student issues regarding academic, career, registration, advising, financial, and
-
, as well as all relevant computer systems. Assists the Radiologist and other physicians with a wide range of sterile procedures, assuring patient safety, comfort, and confidentiality. Performs a variety
-
Scheduled Hours 40 Position Summary Dr. Gomez-Lopez’s research is primarily focused on the immunological pathways that lead to obstetrical disorders, with the goals of improving the understanding
-
Job Description Position Purpose: This position will have a major administrative and program responsibility within the Institute for Protein Design (IPD), Department of Biochemistry in the UW School
-
of circulating factors in human biofluids, such as genetic, epigenetic, or proteins, as potential biomarkers of disease risk, progression or therapeutic outcomes. Dr. Bekris is the new leader of the University